<DOC>
	<DOCNO>NCT00231569</DOCNO>
	<brief_summary>The aim study assess safety vary dos ISIS 301012 subject Stable statin therapy .</brief_summary>
	<brief_title>Dose-escalating Safety Study Subjects Stable Statin Therapy</brief_title>
	<detailed_description />
	<mesh_term>Hypercholesterolemia</mesh_term>
	<mesh_term>Mipomersen</mesh_term>
	<criteria>On stable dose &gt; /= 40 mg Simvastatin atorvastatin daily &gt; /= 3 month prior baseline expect remain dose remainder study LDLcholesterol 2.60 5.70 mmol/L ( 100 220 mg/dL ) , inclusive screening Females childbearing potential . History CHD CHDequivalent ( diabetes mellitus , another clinical form atherosclerotic disease , e.g. , peripheral arterial disease , abdominal aortic aneurysm , symptomatic carotid artery disease ) Fasting triglyceride &gt; 2.26 mmol/L ( 200 mg/dL ) screen Any uncontrolled medical/surgical/psychiatric condition , include condition may predispose secondary hypercholesterolemia Current diagnosis know history complement deficiency abnormality A positive hepatitis B surface antigen hepatitis C antibody , know positive HIV status Current diagnosis know history liver disease , ALT &gt; ULN screen Known history fibromyalgia , myopathy , myositis , rhabdomyolysis , unexplained muscle pain , CPK &gt; ULN screen Malignancy within 5 year , except basal squamous cell carcinoma skin adequately treat The advisability subject take prescription medication ( apart simvastatin atorvastatin ) within 6 week prior screen discuss Isis Medical Monitor Subject unwilling discontinue take alternative/herbal medication duration study History drug abuse within 2 year screen Subject unwilling limit alcohol consumption duration study : male subject maximum 3 drink ( 30 g ) per day , &lt; 12 drink ( 120 g ) per week ; female subject maximum 2 drink ( 20 g ) per day , &lt; 8 drink ( 80 g ) per week Known allergy hypersensitivity simvastatin Undergoing undergone treatment another investigational drug , biologic agent , device within 3 month , 3 half life , prior screen , whichever long</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>December 2013</verification_date>
	<keyword>LDL-cholesterol</keyword>
	<keyword>apoB-100</keyword>
	<keyword>apoB-48</keyword>
</DOC>